Clinical Trial Update: Warfarin and Antiplatelet Vascular Evaluation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating warfarin with antiplatelet therapy for peripheral vascular disease and cardiovascular disease; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Peripheral Vascular Disease

Drugs mentioned

• Antiplatelet therapy (antiplatelet agents)
• Warfarin (warfarin)

Snippet

Sponsor: Anand, Sonia, M.D. | Conditions: Peripheral Vascular Diseases, Cardiovascular Diseases | Phase 3 | Status: UNKNOWN